Member Login
  1. Stocks
    2. /
  2. GSK (LSE: GSK)
    3. /

LSE:GSK (GSK)

About GSK

GlaxoSmithKline is one of the worlds leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • GSK (LSE: GSK) Latest News

    The flag of the United States of America flying in front of the Capitol building
    Investing Articles

    Which is better for UK investors, the FTSE 100 or the S&P 500?

    | Alan Oscroft

    Despite being home to mostly international companies, the FTSE 100 has a valuation that's very different from the US stock…

    Read more »

    Investing Articles

    2 FTSE stocks I’d stick in my Stocks and Shares ISA for the long haul

    | Sumayya Mansoor

    A Stocks and Shares ISA is a Foolish favourite as investment vehicles go. Our writer details two picks she’d buy…

    Read more »

    Investing Articles

    A once-in-a-decade chance to get rich by investing in FTSE 100 shares?

    | Charlie Carman

    After lagging overseas stocks for over 10 years, our writer investigates whether FTSE 100 shares could be the smart place…

    Read more »

    Investing Articles

    Down another 6% in a week! So will the GSK share price ever recover?

    | Harvey Jones

    The GSK share price has had a rotten few years and now it's heading south yet again. Investor Harvey Jones…

    Read more »

    Investing Articles

    I want to add these 2 FTSE gems to my Stocks and Shares ISA

    | Charlie Keough

    This Fool wants to make the most of the benefits a Stocks and Shares ISA provides. He's keen on these…

    Read more »

    Passive income text with pin graph chart on business table
    Investing Articles

    3 dirt cheap FTSE 100 stocks I’d consider buying for passive income

    | Paul Summers

    Our Fool likes the look of these stock market juggernauts for the chunky passive income they throw off, not to…

    Read more »

    Investing Articles

    Is the GSK share price the biggest bargain on the FTSE 100?

    | Charlie Keough

    The GSK share price is nearly 10% off its 52-week high, and this Fool is keen to take a closer…

    Read more »

    Chalkboard representation of risk versus reward on a pair of scales
    Investing Articles

    With GSK’s share price down 9%, is it time for me to buy more on the dip?

    | Simon Watkins

    GSK’s share price has dropped on legal risks connected to Zantac. But these may be at a turning point, leaving…

    Read more »

    Investing Articles

    3 passive income stocks I’d buy as a lower-risk investor

    | Paul Summers

    Paul Summers picks out three stocks he'd buy if he had a lower tolerance for risk but still wanted to…

    Read more »

    Investing Articles

    These are my top FTSE 100 picks as recession fears fade

    | Mark David Hartley

    With Bank of America forecasting a recession-free 2024, Mark David Hartley reconsiders some of his favourite FTSE 100 hopefuls.

    Read more »

    Young Caucasian woman with pink her studying from her laptop screen
    Investing Articles

    New to the stock market? Here are 2 stocks for beginners to consider buying

    | Charlie Keough

    It's been a turbulent month for global stock markets. But that shouldn't stop new investors from considering these FTSE 100…

    Read more »

    Abstract bull climbing indicators on stock chart
    Investing Articles

    After strong Q2 results and positive legal news, is GSK’s share price an unmissable bargain?

    | Simon Watkins

    GSK saw core operating profit jump in Q2 and won the latest round in its ongoing legal case, making the…

    Read more »